小智港股覆盤 | 2月8日
今日,港股三大指數集體下跌。截止收盤,恆生指數跌1.02%,報24329點。國企指數跌0.89%,報8513點。恆生科技指數跌1.67%,報5436點。市場約754只個股上漲,957只個股下跌。成交額突破1295.11億港幣,和昨天同期相比增長5.89%。南下資金淨流入14.09億港幣。

盤面上,海運板塊漲幅較前。信源企業集團漲超7%;中遠海控漲超6%;象興國際漲超4%;東方海外國際漲超3%;太平洋航運漲超2%。

航天國防板塊跟隨走強。中航科工漲超2%。

航空板塊活躍。國泰航空漲超2%;中國國航、中國南方航空股份、中國東方航空股份等多股漲超1%。

CRO板塊暴跌。藥明生物跌超22%;藥明康德跌超11%;康龍化成跌超7%;泰格醫藥跌超6%;中國醫療集團跌超4%。野村:維持藥明生物“買入”評級,目標價149.92港元;藥明康德澄清未被美國列入「未經證實名單」,無持有藥明生物股份;康龍化成股東信中康成通過大宗交易減持約70.76萬股。

互聯網醫療板塊多數下跌。阿裏健康跌超7%;醫渡科技跌超4%;中智全球跌超3%;平安好醫生跌超2%。阿裏健康與阿裏巴巴重續廣告及技術服務協議。

商業服務板塊走低。金茂源環保跌超17%;沛然環保、中邦環境等多股跌超6%;瑩嵐集團、標準發展集團等多股跌超5%。沛然環保前三財季純利降86.80%至28萬港元。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.